How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

    The content on this page is not current guidance and is only for the purposes of the consultation process.

    Interventional procedure overview of removal, preservation and reimplantation of ovarian tissue to restore fertility after gonadotoxic treatment

    Closed for comments This consultation ended on at   Request commenting lead permission

    Indications and current treatment

    Some treatments for cancer or other medical conditions can damage the ovaries (gonadotoxic treatment). This can lead to early menopause and infertility.

    There are a number of pharmacologic and surgical strategies that aim to reduce the risk of infertility after gonadotoxic treatment, including ovarian transposition, ovarian suppression, and fertility-sparing surgery.

    Cryopreservation of oocytes or embryos before starting treatment are options for women who wish to preserve their fertility. These both involve ovarian stimulation, which may lead to a delay in treatment. For embryo cryopreservation there is also a need for sperm from either a partner or sperm donor.